MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC).
about
Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteriaNeuroimaging of Peptide-based Vaccine Therapy in Pediatric Brain Tumors: Initial Experience.A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas.Manganese-containing Prussian blue nanoparticles for imaging of pediatric brain tumors.A novel magnetic resonance imaging segmentation technique for determining diffuse intrinsic pontine glioma tumor volume."Occult" post-contrast signal enhancement in pediatric diffuse intrinsic pontine glioma is the MRI marker of angiogenesis?MR imaging assessment of tumor perfusion and 3D segmented volume at baseline, during treatment, and at tumor progression in children with newly diagnosed diffuse intrinsic pontine gliomaPhase I and pharmacokinetic trial of PTC299 in pediatric patients with refractory or recurrent central nervous system tumors: a PBTC study.Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypesApparent diffusion coefficient histogram metrics correlate with survival in diffuse intrinsic pontine glioma: a report from the Pediatric Brain Tumor Consortium.Differences between brainstem gliomas in juvenile and adult rats.Diffuse intrinsic pontine glioma: time for therapeutic optimism.Pediatric brainstem gliomas: new understanding leads to potential new treatments for two very different tumors.Measurable Supratentorial White Matter Volume Changes in Patients with Diffuse Intrinsic Pontine Glioma Treated with an Anti-Vascular Endothelial Growth Factor Agent, Steroids, and Radiation.Diffuse Intrinsic Pontine Glioma: Time for Cautious Optimism.Discrepant longitudinal volumetric and metabolic evolution of diffuse intrinsic Pontine gliomas during treatment: implications for current response assessment strategiesMRI Evaluation of Non-Necrotic T2-Hyperintense Foci in Pediatric Diffuse Intrinsic Pontine Glioma.External validation of the diffuse intrinsic pontine glioma survival prediction model: a collaborative report from the International DIPG Registry and the SIOPE DIPG Registry.Conventional and Advanced Imaging of Diffuse Intrinsic Pontine Glioma.Diffusion-weighted MRI derived apparent diffusion coefficient identifies prognostically distinct subgroups of pediatric diffuse intrinsic pontine glioma.A new era for children with diffuse intrinsic pontine glioma: hope for cure?Diffuse intrinsic pontine gliomas-current management and new biologic insights. Is there a glimmer of hope?Histone H3 K27M mutations in adult cerebellar high-grade gliomas.T2-weighted images are superior to other MR image types for the determination of diffuse intrinsic pontine glioma intratumoral heterogeneity.A pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas.Correlation of 18F-FDG PET and MRI Apparent Diffusion Coefficient Histogram Metrics with Survival in Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium.Citrate concentrations increase with hypoperfusion in pediatric diffuse intrinsic pontine glioma.Biomarker-Based PET Imaging of Diffuse Intrinsic Pontine Glioma in Mouse Models.Cerebral blood flow changes after radiation therapy identifies pseudo-progression in diffuse intrinsic pontine gliomas.Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood.The Integration of Biology Into the Treatment of Diffuse Intrinsic Pontine Glioma: A Review of the North American Clinical Trial Perspective.Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries.Challenges with defining response to antitumor agents in pediatric neuro-oncology: A report from the response assessment in pediatric neuro-oncology (RAPNO) working group
P2860
Q30829348-13AE5F3E-450A-42DE-B5AE-FD6A125F3FD0Q31144824-50A27158-6CB4-4DA3-9733-FE4D9B301119Q33428049-EAF84A18-8D6A-449F-B326-6442E0A83F29Q33706579-46832190-7D96-4221-8E2D-DDE3984B3E3DQ33874889-36377DF5-D7CB-491A-843E-10FCA14D7CD3Q34598854-91776C24-6BAD-4FF5-9AA4-7DC912A4C663Q34598895-20407F81-F0C6-43AD-BB74-998589C580C8Q35090526-CC59B19C-650A-4A04-BAA1-0960ED9562F8Q36303824-480F01C8-7D55-4E32-905C-FC94F5A1182FQ36785126-49595849-923C-4D3B-8024-01CA698EF448Q37093507-BDA5019A-B8C5-4F58-9EE3-67CACE1CCF02Q38264309-531B8AD5-2FB4-46AE-8531-A2712CB0FC3AQ38363549-FC3C23D6-E9CB-4BED-87D1-C0AC187E405EQ38827788-C9C495CC-C249-463F-B975-0FF7B528F359Q38963434-30C3C1D4-D633-4698-A996-C705686FC00DQ39580234-46FC57B9-F477-471E-BB1D-9CB1CF7A3351Q39752215-EEE4BE26-75E8-4F6F-8B8D-F6104569F89BQ40179571-B8195FDC-BC70-47E4-80BB-E7DCF2993C40Q42616334-77707C94-FF27-4CA5-A26E-582E8EEEAB34Q46412744-EEC71D79-249C-4DC6-A677-4B0BE6CBD4D2Q47563055-BC35A60E-938A-4A53-9D81-D089F3BD55D3Q47580461-8747C129-2E55-4706-89C7-E43907228800Q47751767-899842B1-2497-4130-8289-2B51B32087B0Q47832897-4A0D0D0C-3E96-4BB7-832B-6E512A7DF1D2Q47992039-AA55B90B-9856-4CCF-B536-5534DF63E9C2Q48237727-B43096AF-391D-44F0-BBDE-BFF5B76D8C96Q48334821-6952D096-AEBB-4042-BC49-EB1604CD4E57Q48347188-DF9D5389-53B7-4065-A254-E3AFB88C2B1DQ49825613-94E9AC8E-B205-4B9C-A306-624915DDFB8DQ51744172-F7FAD8A3-4866-49F4-9D5E-29B492F83B5CQ55021530-4725383C-0048-4925-B893-56BC02619F02Q55456557-386E1269-8B83-430C-AE58-66DFBD40589DQ58001390-9474684D-8119-4C8D-B3F6-0F82DF50F3EC
P2860
MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC).
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
MRI as a central component of ...... Brain Tumor Consortium (PBTC).
@ast
MRI as a central component of ...... Brain Tumor Consortium (PBTC).
@en
MRI as a central component of ...... diatric Brain Tumor Consortium
@nl
type
label
MRI as a central component of ...... Brain Tumor Consortium (PBTC).
@ast
MRI as a central component of ...... Brain Tumor Consortium (PBTC).
@en
MRI as a central component of ...... diatric Brain Tumor Consortium
@nl
prefLabel
MRI as a central component of ...... Brain Tumor Consortium (PBTC).
@ast
MRI as a central component of ...... Brain Tumor Consortium (PBTC).
@en
MRI as a central component of ...... diatric Brain Tumor Consortium
@nl
P2093
P2860
P356
P1433
P1476
MRI as a central component of ...... Brain Tumor Consortium (PBTC).
@en
P2093
Daphne Haas-Kogan
Gilbert Vezina
Ian F Pollack
James M Boyett
Larry E Kun
Robert Zimmerman
Roger I Packer
Russell Geyer
Soonmee Cha
Sridhar Vajapeyam
P2860
P304
P356
10.1093/NEUONC/NOQ200
P577
2011-02-04T00:00:00Z